Timothy P. Hughes - Concepedia

Author

Timothy P. Hughes

Also Known As

Greenblatt, Jack, Hughes, Timothy, Hyun-Gyung Goh, Jerald P. Radich, Kucharska-Newton, Anna M., Susan Branford, T Hughes, T P Hughes, T. Hughes, T. P. HUGHES

798

Publications

55.3K

Citations

H-Index

133

Concepts

All Affiliations

South Australia Pathology The University of Adelaide South Australian Health and Medical Research Institute The University of Texas MD Anderson Cancer Center Centre for Cancer Biology

About

Timothy P. Hughes is an author at South Australia Pathology specializing in medicine, hematology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	41	87	10.6K
2	Health Sciences	20	31	3.8K
3	Engineering	4	4	167
4	Natural Sciences	3	3	314
5	Public Health	3	3	114

Timothy P. Hughes

302

Publications

45.2K

Citations

H-Index

Page 1

	Year	Citations
Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Stephen G. O’Brien, François Guilhot, Richard A. Larson, New England Journal of Medicine	2003	3.5K
Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia Brian Druker, François Guilhot, Stephen G. O’Brien, New England Journal of Medicine	2006	3.5K
Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia Giuseppe Saglio, Dong‐Wook Kim, Surapol Issaragrisil, New England Journal of Medicine	2010	1.7K
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia Kathryn G. Roberts, Yongjin Li, Debbie Payne-Turner, New England Journal of Medicine	2014	1.4K
Frequency of Major Molecular Responses to Imatinib or Interferon Alfa plus Cytarabine in Newly Diagnosed Chronic Myeloid Leukemia Timothy P. Hughes, Jaspal Kaeda, Susan Branford, New England Journal of Medicine	2003	1.2K
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia Andreas Hochhaus, Richard A. Larson, François Guilhot, New England Journal of Medicine	2017	1.2K
A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias Jörge E. Cortes, D. W. Kim, Javier Pinilla‐Ibarz, New England Journal of Medicine	2013	1.1K
BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros Charles G. Mullighan, Christopher B. Miller, Ina Radtke, Nature Hematological MalignancyBcr–abl1 Lymphoblastic LeukaemiaHematologyImmunologyPathology	2008	1.1K
Experimental Campylobacter jejuni Infection in Humans R.A. Black, Myron M. Levine, M L Clements, The Journal of Infectious Diseases	1988	1K
Dynamics of chronic myeloid leukaemia Franziska Michor, Timothy P. Hughes, Yoh Iwasa, Nature Hematological MalignancyTumor BiologyChronic Myeloid LeukaemiaMedicineMixed-phenotype Acute Leukemia	2005	848

Page 1